Immunome (IMNM.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec23

Isaac Barchas Disposes of Immunome Inc. Shares

21:42

Dec22

Immunome Inc. CTO Philip Tsai Buys Company Shares

12:33

Dec18

Immunome CEO Acquires Company Shares

22:04

Dec17

Immunome Launches Follow-On Public Offering to Raise $400 Million

22:26

Dec16

Craig-Hallum Analyst Reiterates Buy Rating on Immunome

14:57

Dec15

Immunome Announces Positive Phase III Trial Results for Varegacestat and Plans to Submit New Drug Application

12:02

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -57.46 M, EPS -0.6532

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.015 M, Net Income -43.4 M, EPS -0.4987

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 2.926 M, Net Income -41.64 M, EPS -0.5243

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More